ACTRN12605000167662
Recruiting
Phase 1
A double blind randomised placebo-controlled intervention trial to determine the efficacy of the probiotic VSL #3 in reducing the incidence and or frequency of diarrhoea in enterally-fed critically ill patients.
Department of Health and Human Services (Tasmanian Government)0 sites100 target enrollmentAugust 17, 2005
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Diarrhoeal illness and infection in critically ill patients
- Sponsor
- Department of Health and Human Services (Tasmanian Government)
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All prospective adult participants that may require tube feeding as part of their routine management of their illness while a patient admitted to the ICU will be screened preoperatively in the pre\-admission clinic or on admission to the ICU.
Exclusion Criteria
- •Patients with the following characteristics would be excluded from the study; \< 18 years Likely to be tube fed \< 48 hours Allergy to milk preparations Present with special dietary requirements (other than diabetic or renal considerations) requiring Total Parenteral Nutrition (TPN) Present with any condition that might interfere with the delivery of enteral feeds such as obstruction of the gastrointestinal tract.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Clinical and physiological evaluation of a Chinese herbal medicine for constipation-predominant Irritable Bowel Syndrome (C-IBS Trial).Constipation-predominant Irritable Bowel SyndromeAlternative and Complementary Medicine - Herbal remediesACTRN12609000558224niversity of Western Sydney160
Not yet recruiting
Phase 3
A double blind randomised placebo controlled clinical trial for evaluating the efficacy of Eranda Patra Kshara and Hingu churna with lifestyle modification in the management of Non-alcoholic fatty liver diseaseCTRI/2023/04/052096All India Institute of Ayurveda
Not yet recruiting
Not Applicable
The Indacaterol in Lymphangioleiomymotosis (LAM) TrialymphangioleiomyomatosisLymphangioleiomyomatosisRespiratory - Other respiratory disorders / diseasesACTRN12613001251718Deborah H Yates15
Active, not recruiting
Phase 1
se of low-dose zolpidem in Parkinson's.EUCTR2017-004297-34-GBAston University28
Completed
Not Applicable
A feasibility study of octreotide infusion during liver transplantPerioperative bleeding, liver transplantSurgeryISRCTN17573492niversity College London30